• Je něco špatně v tomto záznamu ?

Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner

J. Barbaric, M. Sekerija, D. Agius, D. Coza, N. Dimitrova, A. Demetriou, C. Safaei Diba, S. Eser, Z. Gavric, M. Primic-Zakelj, S. Zivkovic, M. Zvolsky, F. Bray, JW. Coebergh, A. Znaor,

. 2016 ; 55 (-) : 47-55. [pub] 20160109

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu srovnávací studie, časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc16020015

INTRODUCTION: Most countries in South-Eastern Europe (SEE) have lower incidence, but higher mortality rates of malignant melanoma (MM) of the skin compared to North-Western Europe (NWE). We explored trends in MM incidence and mortality in SEE countries by sex and age and compared them with the trends in NWE. METHODS: We obtained data on incident cases and deaths from MM (ICD-10 code C43) from 11 population-based cancer registries in Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Malta, Romania, Serbia, Slovakia, Slovenia and Turkey. We calculated age-specific rates for 25-49 ('young'), 50-69 ('middle aged') and 70+ years ('older') and estimated the average annual percent of change in incidence and mortality trends 2000-2010 according to age group and sex, using joinpoint regression analysis. FINDINGS: The incidence rates of MM across the region were uniformly increasing. Significant increases in mortality rates were observed in middle aged men in Serbia and Bulgaria, middle aged women in Slovenia, older men in the Czech Republic, Serbia and Turkey, and older women in Slovenia and Serbia. INTERPRETATION: While MM incidence rates were still increasing across SEE, mortality trends diverged and were less favourable than in NWE. Empowering cancer registration and improving the quality of incidence and mortality data will be essential for monitoring progress in MM control. In the context of prevention of melanoma, disparities in early detection appear to be widening the gap between SEE and NWE, while the provision of care to patients with advanced disease is likely to prove a challenge for regional healthcare budgets.

Agency for Quality and Accreditation in Health Care and Social Welfare Department for Development Research and Health Technology Assessment Planinska 13 10000 Zagreb Croatia

Bulgarian National Cancer Registry National Oncology Hospital 6 Plovdivsko Pole Street 1756 Sofia Bulgaria

Cancer Registry of Central Serbia Institute of Public Health of Serbia Dr Subotica 5 11000 Belgrade Serbia

Cancer Registry of Republic of Slovenia Oncology Institute of Oncology Ljubljana Zaloska 2 1000 Ljubljana Slovenia

Cancer Registry of Republic of Srpska The Public Health Institute Banja Luka Jovan Ducic 1 78 000 Banja Luka Bosnia and Herzegovina

Croatian National Cancer Registry Croatian Institute of Public Health Rockefellerova 7 10000 Zagreb Croatia

Cyprus Cancer Registry Health Monitoring Unit Ministry of Health 1 Prodromou Street and 17 Chilonos Street 1448 Lefkosia Cyprus

Czech National Cancer Registry Institute of Health Information and Statistics of the Czech Republic Palackého nám 4 PO Box 60 128 01 Praha 2 Czech Republic

Department of Public Health Erasmus University Medical Center PO Box 2040 3000 CA Rotterdam The Netherlands

Hacettepe University Public Health Institute Sıhhıye Campus Sıhhıye 06100 Ankara Turkey

Izmir Cancer Registry Izmir Public Health Directorate Zubeyde Hanim Caddesi No 100 35067 Karsiyaka Izmir Turkey

Malta National Cancer Registry Department for Health Information and Research 95 G'Mangia Hill Pieta PTA 1313 Malta

National Cancer Registry of Slovakia National Health Information Center Lazaretska 26 81109 Bratislava Slovakia

Regional Cancer Registry of Cluj Oncological Institute 'Ion Chiricuta' Republicii Street 34 36 400015 Cluj Napoca Romania

Section of Cancer Surveillance International Agency for Research on Cancer 150 Cours Albert Thomas 69372 CEDEX 08 Lyon France

000      
00000naa a2200000 a 4500
001      
bmc16020015
003      
CZ-PrNML
005      
20170322194032.0
007      
ta
008      
160722s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejca.2015.11.019 $2 doi
024    7_
$a 10.1016/j.ejca.2015.11.019 $2 doi
035    __
$a (PubMed)26773419
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Barbaric, Jelena $u Agency for Quality and Accreditation in Health Care and Social Welfare, Department for Development, Research and Health Technology Assessment, Planinska 13, 10000 Zagreb, Croatia. Electronic address: j_barbaric@yahoo.com.
245    10
$a Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner / $c J. Barbaric, M. Sekerija, D. Agius, D. Coza, N. Dimitrova, A. Demetriou, C. Safaei Diba, S. Eser, Z. Gavric, M. Primic-Zakelj, S. Zivkovic, M. Zvolsky, F. Bray, JW. Coebergh, A. Znaor,
520    9_
$a INTRODUCTION: Most countries in South-Eastern Europe (SEE) have lower incidence, but higher mortality rates of malignant melanoma (MM) of the skin compared to North-Western Europe (NWE). We explored trends in MM incidence and mortality in SEE countries by sex and age and compared them with the trends in NWE. METHODS: We obtained data on incident cases and deaths from MM (ICD-10 code C43) from 11 population-based cancer registries in Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Malta, Romania, Serbia, Slovakia, Slovenia and Turkey. We calculated age-specific rates for 25-49 ('young'), 50-69 ('middle aged') and 70+ years ('older') and estimated the average annual percent of change in incidence and mortality trends 2000-2010 according to age group and sex, using joinpoint regression analysis. FINDINGS: The incidence rates of MM across the region were uniformly increasing. Significant increases in mortality rates were observed in middle aged men in Serbia and Bulgaria, middle aged women in Slovenia, older men in the Czech Republic, Serbia and Turkey, and older women in Slovenia and Serbia. INTERPRETATION: While MM incidence rates were still increasing across SEE, mortality trends diverged and were less favourable than in NWE. Empowering cancer registration and improving the quality of incidence and mortality data will be essential for monitoring progress in MM control. In the context of prevention of melanoma, disparities in early detection appear to be widening the gap between SEE and NWE, while the provision of care to patients with advanced disease is likely to prove a challenge for regional healthcare budgets.
650    _2
$a dospělí $7 D000328
650    _2
$a věkové rozložení $7 D017677
650    _2
$a senioři $7 D000368
650    _2
$a časná detekce nádoru $7 D055088
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dostupnost zdravotnických služeb $7 D006297
650    12
$a disparity zdravotního stavu $7 D054624
650    12
$a disparity zdravotní péče $x trendy $7 D054625
650    _2
$a lidé $7 D006801
650    _2
$a incidence $7 D015994
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a melanom $x diagnóza $x epidemiologie $x mortalita $x prevence a kontrola $7 D008545
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mortalita $x trendy $7 D009026
650    _2
$a registrace $7 D012042
650    _2
$a rizikové faktory $7 D012307
650    _2
$a rozložení podle pohlaví $7 D017678
650    _2
$a nádory kůže $x diagnóza $x epidemiologie $x mortalita $x prevence a kontrola $7 D012878
650    _2
$a časové faktory $7 D013997
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Sekerija, Mario $u Croatian National Cancer Registry, Croatian Institute of Public Health, Rockefellerova 7, 10000 Zagreb, Croatia. Electronic address: mario.sekerija@hzjz.hr.
700    1_
$a Agius, Dominic $u Malta National Cancer Registry, Department for Health Information and Research, 95, G'Mangia Hill, Pieta, PTA 1313, Malta. Electronic address: domenic.a.agius@gov.mt. $7 gn_A_00002181
700    1_
$a Coza, Daniela $u Regional Cancer Registry of Cluj, Oncological Institute 'Ion Chiricuta', Republicii Street 34-36, 400015 Cluj-Napoca, Romania. Electronic address: dana.coza@iocn.ro.
700    1_
$a Dimitrova, Nadya $u Bulgarian National Cancer Registry, National Oncology Hospital, 6, Plovdivsko Pole Street, 1756 Sofia, Bulgaria. Electronic address: dimitrova.nadia@gmail.com.
700    1_
$a Demetriou, Anna $u Cyprus Cancer Registry-Health Monitoring Unit, Ministry of Health, 1 Prodromou Street & 17 Chilonos Street, 1448 Lefkosia, Cyprus. Electronic address: ADemetriou@moh.gov.cy.
700    1_
$a Safaei Diba, Chakameh $u National Cancer Registry of Slovakia, National Health Information Center, Lazaretska 26, 81109 Bratislava, Slovakia. Electronic address: Chakameh.DibaSafaei@nczisk.sk.
700    1_
$a Eser, Sultan $u Hacettepe University, Public Health Institute, Sıhhıye Campus, Sıhhıye, 06100 Ankara, Turkey; Izmir Cancer Registry, Izmir Public Health Directorate, Zubeyde Hanim Caddesi No:100, 35067 Karsiyaka, Izmir, Turkey. Electronic address: sultan.eser@gmail.com.
700    1_
$a Gavric, Zivana $u Cancer Registry of Republic of Srpska, The Public Health Institute Banja Luka, Jovan Ducic 1, 78 000 Banja Luka, Bosnia and Herzegovina. Electronic address: zgavric210@gmail.com.
700    1_
$a Primic-Zakelj, Maja $u Cancer Registry of Republic of Slovenia, Oncology Institute of Oncology Ljubljana, Zaloska 2, 1000 Ljubljana, Slovenia. Electronic address: mzakelj@onko-i.si.
700    1_
$a Zivkovic, Snezana $u Cancer Registry of Central Serbia, Institute of Public Health of Serbia, Dr Subotica 5, 11000 Belgrade, Serbia. Electronic address: snezana_zivkovic@batut.org.rs.
700    1_
$a Zvolský, Miroslav $u Czech National Cancer Registry, Institute of Health Information and Statistics of the Czech Republic, Palackého nám. 4, PO Box 60, 128 01 Praha 2, Czech Republic. Electronic address: miroslav.zvolsky@uzis.cz. $7 xx0096967
700    1_
$a Bray, Freddie $u Section of Cancer Surveillance, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 CEDEX 08 Lyon, France. Electronic address: BrayF@iarc.fr.
700    1_
$a Coebergh, Jan Willem $u Department of Public Health, Erasmus University Medical Center, PO Box 2040 3000 CA Rotterdam, The Netherlands. Electronic address: j.coebergh@erasmusmc.nl.
700    1_
$a Znaor, Ariana $u Section of Cancer Surveillance, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69372 CEDEX 08 Lyon, France. Electronic address: ZnaorA@iarc.fr.
773    0_
$w MED00009626 $t European journal of cancer (Oxford, England 1990) $x 1879-0852 $g Roč. 55, č. - (2016), s. 47-55
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26773419 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20170322194309 $b ABA008
999    __
$a ok $b bmc $g 1154685 $s 944543
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 55 $c - $d 47-55 $e 20160109 $i 1879-0852 $m European journal of cancer $n Eur J Cancer $x MED00009626
LZP    __
$a Pubmed-20160722

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...